Back to Dashboard
55

SHC

🏥 Healthcare

Sotera Health Company

Conservative #469Aggressive #546Low RiskML↑ 30pt
$16.47+1.92%
Day High$16.52
Day Low$16.10
Volume2.0M
Mkt Cap$4.7B
52W Low $1052W High $20
Market Cap
$4.9B
P/E Ratio
85.6
Sector avg: 41.9
Rev Growth
4.9%
Sector avg: 161.5%
Earnings Growth
-13.6%
Profit Margin
4.0%
Sector avg: -3292.7%
Debt/Equity
5.81

Why This Score

SHC scores 55.6 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.

Strengths
  • Positive but moderate momentum (37%) — steady appreciation without overheating.
Risk Factors
  • Elevated valuation at 85.6x earnings — requires sustained growth to justify the premium.
  • Above-average volatility (12.8%) may not suit conservative risk tolerance.
  • Elevated leverage (D/E 5.81) increases financial risk in a rising-rate environment.

Minor adjustments (0.0 points) applied. SHC's rank of #469 primarily reflects its factor profile relative to the conservative weight vector.

Score Breakdown

Overall Score55.6
Fundamental Score51.5
ML Score52.0

Score by Horizon

3 Month
80.9
6 Month
90.4
Primary
1 Year
95.1

Quality Assessment

C
Quality Grade
Average quality — moderate profitability or leverage
1 quality flag detected — see details below. These penalties are already factored into the final score.
Quality Flags
Extreme leverage: D/E ratio of 5.8x — balance sheet risk

Position Sizing

Suggested Allocation
5%
Confidence
high

Score Composition Waterfall

How each component affects the final score
Backtested Scoring Levers (IC-calibrated from 30y ElasticNet)
Weinstein (12.1%)
100
Advancing
Sentiment (2.5%)
73
Positive
Analyst (6.4%)
73
Favorable
Tradability (post-hoc)
92
Grade A
Base
51.6
SHAP
+2.6
Factors
+1.4
Final
55.6
Positive adjustment
Negative adjustment
Base blend
Final score

Factor Breakdown

51AVG
Value40
Quality55
Growth45
Stability35
Investment80

Signal SegmentsComputed from ML features

Fundamental (Valuation, Quality, Growth)32.0
Technical (Momentum, Weinstein, Volatility)80.0
External (Sentiment, Analyst, Macro)87.0
Scores below 50 indicate weakness in that segment relative to the universe.

Data Quality

Score
Features
Confidence
Feature Coverage96%

Growth Estimates

Short-term
+11.4% to +17.6%
Medium-term
+16.8% to +26.0%
Long-term
+24.9% to +37.6%

ML Model Core Features100 trained inputs → ML Score: 52

These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.

Analyst Intelligence
Consensus Score72.9/100
Target Upside+30.1%
Coverage12 analysts
Market Sentiment
Sentiment Score73.2/100
News Volume1 articles
Technical Stage
Weinstein Stage2 — Advancing
12M Momentum+0.4%
6M Momentum+0.0%
Volatility+0.1%
Momentum & Technical
Momentum Acceleration+32.7%
Momentum ConsistencyWeak (0.12)
Relative Strength vs Sector+12.9%
Trend Strength (ADX Proxy)Moderate (2.9)
Momentum Quality+0.339
Momentum BreadthBroad ✓
Macro Regime
Bull RegimeYes
High Vol RegimeNo
S&P 500 Return+25.0%
Yield Curve-0.1bp

Sector-Relative AnalysisIn-model features

Value Trap Signal
2%
Low risk
Sector RevGr Rank
P49
Revenue growth vs Healthcare peers
Sector PE Rank
P4
Valuation vs Healthcare peers
Sector FCF Rank
P89
Free cash flow vs Healthcare peers
Growth Deviation
-0.0σ
Z-score vs sector median
Stagnation Flag
NO
Not flagged

Analysis Signals

Scoring Factors
Fundamental score of 52 relative to sector peers52/100
Machine learning ensemble ranks this stock at the 52th percentileP52
Blended score: 80% fundamental (52) + 20% ML (52) = 51.651.6
Risk assessment: low. Low vol 0.1%; Drawdown 9% → 0.0ptLow
Earnings quality grade C: mixed earnings quality, some red flags. Score adjusted by 0 pointsGrade C
SHAP feature alignment: +2.6pt (features align with model priorities)SHAP
Risk Factors
Quality concern: Extreme leverage: D/E ratio of 5.8x — balance sheet riskFlag

Sector Peer Comparison(Healthcare — Rank #60 of 344 stocks)

StockScoreP/ERev GrowthMarginMkt Cap
SHC55.685.64.9%4.0%$4.9B
INCY89.915.821.2%25.0%$19.6B
GMAB86.113.122.8%36.4%$17.9B
CPRX83.713.723.5%37.6%$3.0B
ASND78.316.698.0%-31.7%$13.8B
EXEL78.315.17.0%33.7%$11.9B
VRTX78.232.18.9%32.9%$121.8B
NBIX75.126.521.4%16.7%$13.1B
RPRX75.025.15.1%32.4%$19.3B
HOLX74.831.11.7%13.8%$16.8B
AMGN74.226.010.0%21.0%$204.8B
ARGX73.735.178.6%38.0%$47.4B
REGN73.019.41.0%31.4%$80.2B
ALKS72.916.5-6.4%23.9%$5.0B
ISRG72.761.720.5%28.4%$180.9B
KRYS71.541.4473.0%30.7%$7.9B
Sector Average36.641.9161.5%-3292.7%—

Company Overviewvia FMP

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

CEO
Michael Petras Jr.
Employees
3,000
Beta
1.83
Industry
Medical - Diagnostics & Research
FMP-Identified Peers

Technical Picturecomputed from daily prices

RSI (14)
36.9
Neutral
Trend
Bearish
10-day vs 50-day MA
From 52W High
-17%
High: $19.85
From 52W Low
+72.8%
Low: $9.53
Moving Averages
10-Day
$17.00
Below
20-Day
$17.40
Below
50-Day
$17.90
Below
200-Day
$15.30
Above
60-Day Support
$15.96
60-Day Resistance
$19.85
Weinstein Stage Analysisbased on 200-day SMA framework
Stage 2 — AdvancingScore: 75/100

Stock is in an uptrend above the 200-day moving average. This is the stage where institutional accumulation typically occurs. The 50-day SMA provides support.

Favorable technical position; 50-day SMA acts as support
Price vs 200 SMA
+7.6%
200 SMA Slope (60d)
+13.02%
Rising
Volume Ratio
1x
10d avg vs 50d avg
Days in Stage
100
Confidence: 90%

Financial Statementslast 4 quarters via FMP

MetricQ4 2025Q3 2025Q2 2025Q1 2025
Revenue$303M$311M$294M$255M
Gross Profit$166M$178M$167M$135M
Operating Income$136M$111M$88M$57M
Net Income$35M$48M$8M$-13M
EPS (Diluted)$0.12$0.17$0.03$-0.05
Gross Margin54.7%57.0%56.6%53.2%
Operating Margin44.9%35.7%30.0%22.4%
Net Margin11.5%15.5%2.7%-5.2%

Why This Stock

Healthcare

Tradability FilterGrade A — 92/100Score impact: +0.9pt

Volume
100
1.9M avg/day
Dollar Vol
89
$34M/day
Float
100
153M shares
Mkt Cap
67
$4.9B
Range
100
108% spread
Composite Liquidity Score92/100
FDCBA

Multi-Year Range Analysis

Sideways: 0/100
YearLowHighRangeStatus
2021$20.48$30.3838.9%Wide
2022$5.78$24.90124.6%Wide
2023$8.02$19.4083%Wide
2024$10.71$17.4447.8%Wide
2025$9.53$17.8360.7%Wide
3-Year Range
83%
Narrow Years
0 / 5
Sideways Penalty
None
Free Float
54.0%
Outstanding Shares
284M
Bid-Ask Spread
108.0%
Institutional Tradable
Yes

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.